Scarica l'app Stockscreener
5.95
2.30%
-0.14
Precedente Chiudi:
$6.09
Aprire:
$5.96
Volume 24 ore:
98,705
Relative Volume:
1.92
Capitalizzazione di mercato:
$141.65M
Reddito:
$40,000
Utile/perdita netta:
$-67.82M
Rapporto P/E:
-1.6721
EPS:
-3.5583
Flusso di cassa netto:
$-20.86M
1 W Prestazione:
-18.27%
1M Prestazione:
-40.05%
6M Prestazione:
-47.76%
1 anno Prestazione:
-15.00%
Intervallo 1D:
$5.48
$6.23
Intervallo di 1 settimana:
$5.48
$7.54
Portata 52W:
$3.20
$15.50
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
Nome
Neonc Technologies Holdings Inc
Settore
Industria
Telefono
310 663 7831
Indirizzo
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
5.95 | 141.65M | 40,000 | -67.82M | -20.86M | -3.5583 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Neonc Technologies Holdings Inc Borsa (NTHI) Ultime notizie
NeOnc Technologies Reports Q4 2025 Results, Advances NEO100 & NEO212 Clinical Trials, and Secures $10M PIPE Financing - Minichart
NTHI 8-K & SEC Filings - Yahoo Finance Australia
NeOnc Technologies Reports Q4 Results and Trial Progress - TipRanks
NeOnc (Nasdaq: NTHI) details Q4 results, trial data and $10M PIPE - stocktitan.net
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo Finance
NeOnc Technologies settles dispute with Fox Infused for $737,920.77 payment - Investing.com
Neonc Technologies Holdings Says Co May Offer Up To $300 Million Of Securities - TradingView
NeOnc (NASDAQ: NTHI) files $300M shelf to sell stock, debt and warrants - stocktitan.net
NeOnc Provides Business Update and Reports Q4 2025 Financial Results - Sahm
Brain cancer drug data in 5 months as NeOnc posts $62.1M Q4 loss - stocktitan.net
NTHI Should I Buy - Intellectia AI
NeOnc Technologies: Innovative Drug Delivery Platforms and Pipeline for Brain Cancer and CNS Disorders - Minichart
Neonc Technologies Holdings 10-K — Revenue $0.04M; EPS (3.20) - TradingView
NeOnc Technologies (NTHI) details NEO100, NEO212 trials and AI-driven CNS oncology platform in 2025 10-K - stocktitan.net
NeOnc Technologies Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Aug Opening: How do insiders feel about NeOnc Technologies Holdings IncMarket Sentiment Summary & Momentum Based Trading Signals - baoquankhu1.vn
Aug Swings: Can NeOnc Technologies Holdings Inc weather a recessionWeekly Trade Analysis & Community Trade Idea Sharing Platform - baoquankhu1.vn
Swing Trade: Is NeOnc Technologies Holdings Inc exposed to political riskPrice Action & High Accuracy Investment Signals - baoquankhu1.vn
Resistance Check: Is NeOnc Technologies Holdings Inc affected by consumer sentiment2026 Gainers & Stock Timing and Entry Methods - baoquankhu1.vn
Dip Buying: What are analysts price targets for NeOnc Technologies Holdings Inc2026 Earnings Impact & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
New to The Street Signs NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI) to 12-Part National Broadcast Series Including T.V. Network Features, Earned Media, Commercials, and Iconic Outdoor Billboards - The Herald-Mail
NeOnc Announces New Private Placement to Support Liquidity - TipRanks
NeOnc Technologies Holdings, Inc. Signs Material Definitive Agreements for Securities Purchase and Warrants – SEC Filing Details - Minichart
NeOnc Technologies Launches Third Equity Round: Up to 545,583 Shares at $7.20, $1M First Close - tradingview.com
NeOnc Technologies (NASDAQ: NTHI) raises $1M in private stock and warrant deal - stocktitan.net
Breakouts Watch: What is the implied volatility of NeOnc Technologies Holdings Inc2026 Spike Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
NeOnc Technologies Holdings, Inc. announced that it expects to receive $3.928198 million in funding - marketscreener.com
Neonc Technologies (NTHI) to Release Earnings on Friday - Defense World
Swing Trade: Will NeOnc Technologies Holdings Inc benefit from government policyTrade Exit Report & Fast Gain Swing Trade Alerts - baoquankhu1.vn
NeOnc Technologies Appoints David Choi as Chief Accounting Officer to Strengthen Financial Leadership Amid Clinical Expansion - Minichart
Trade Recap: Does NeOnc Technologies Holdings Inc have declining or rising EPSQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
NeOnc Technologies Appoints New Chief Accounting Officer - TipRanks
Neonc appoints David Choi as Chief Accounting Officer - TradingView
NeOnc Technologies appoints David Choi as chief accounting officer - Investing.com India
NeOnc Technologies appoints David Choi as chief accounting officer By Investing.com - au.investing.com
Neonc Technologies Stock Price Dips 0.1% - National Today
NeOnc Technologies Holdings, Inc. Appoints David Choi as Chief Accounting Officer - marketscreener.com
NeOnc Technologies Appoints David Choi as Chief Accounting Officer - GlobeNewswire
Latest NTHI NewsNeOnc Technologies Announces Near Completio... - stocktitan.net
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - marketscreener.com
New brain cancer chemo targets blood-brain barrier as NeOnc adds $16M - stocktitan.net
Neonc Technologies (NASDAQ:NTHI) Trading Down 0.1% – Should You Sell? - Defense World
NeOnc sets Phase 2 dose for brain cancer drug NEO212 - Investing.com Nigeria
Surprises Report: Is NeOnc Technologies Holdings Inc. stock oversold or undervaluedPortfolio Return Report & Scalable Portfolio Growth Methods - Naître et grandir
NeOnc Reports Phase 1 NEO212 Results, Sets Phase 2 Dose - TipRanks
NeOnc Technologies Reports RP2D of 610 mg for Oral NEO212 after Phase 1 Dose-Escalation - TradingView
Breakouts Watch: Is NeOnc Technologies Holdings Inc affected by consumer sentiment2025 Trading Volume Trends & Verified Stock Trade Ideas - baoquankhu1.vn
Published on: 2026-03-05 20:09:42 - baoquankhu1.vn
NeOnc Technologies Settles Fox Infused Dispute With Payment - TipRanks
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET - Bitget
Earnings Risk: Will NeOnc Technologies Holdings Inc benefit from government policy2025 Earnings Surprises & Weekly Top Stock Performers List - baoquankhu1.vn
Neonc Technologies Holdings Inc Azioni (NTHI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):